ABCB4 exports phosphatidylcholine in a sphingomyel-independent manner

Journal of Lipid Research

Volumn 56, Issue 3, 2015, Pages 644-652

  Zhao, Yu ^a   Ishigami, Masato ^b   Nagao, Kohjiro ^a,e   Hanada, Kentaro ^c   Kono, Nozomu ^d   Arai, Hiroyuki ^d   Matsuo, Michinori ^b,f   Kioka, Noriyuki ^b   Ueda, Kazumitsu ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

( 1R,3S ) N (3 hydroxy 1 hydroxymethyl 3 phenylpropyl)dodecanamide; ATP binding cassette protein; ATP binding cassette transporter A1; Bile acid; Cholesterol; High density lipoprotein; Myriosin

Indexed keywords

ABC TRANSPORTER A1; AMIDE; MULTIDRUG RESISTANCE PROTEIN 3; N (3 HYDROXY 1 HYDROXYMETHYL 3 PHENYLPROPYL) DODECANAMIDE; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; THERMOZYMOCIDIN; UNCLASSIFIED DRUG; ABCA1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; LIPID TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; ACTIVE TRANSPORT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MEMBRANE; GENETICS; HAMSTER; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY;

ANIMALS; ATP BINDING CASSETTE TRANSPORTER 1; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; CRICETINAE; HEK293 CELLS; HUMANS; P-GLYCOPROTEINS; PHOSPHATIDYLCHOLINES; SPHINGOMYELINS;

EID: 84925340682     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M056622     Document Type: Article

References (38)

1. Smit, J. J., A. H. Schinkel, R. P. Oude Elferink, A. K. Groen, E. Wagenaar, L. van Deemter, C. A. Mol, R. Ottenhoff, N. M. van der Lugt, M. A. van Roon, et al. 1993. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75: 451-462.
2. Oude Elferink, R. P., and C. C. Paulusma. 2007. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch. 453: 601-610.
3. de Vree, J. M., E. Jacquemin, E. Sturm, D. Cresteil, P. J. Bosma, J. Aten, J. F. Deleuze, M. Desrochers, M. Burdelski, O. Bernard, et al. 1998. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl. Acad. Sci. USA. 95: 282-287.
4. Deleuze, J. F., E. Jacquemin, C. Dubuisson, D. Cresteil, M. Dumont, S. Erlinger, O. Bernard, and M. Hadchouel. 1996. Defect of multi-drug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology. 23: 904-908.
5. Lucena, J. F., J. I. Herrero, J. Quiroga, B. Sangro, J. Garcia-Foncillas, N. Zabalegui, J. Sola, M. Herraiz, J. F. Medina, and J. Prieto. 2003. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology. 124: 1037-1042.
6. van der Bliek, A. M., P. M. Kooiman, C. Schneider, and P. Borst. 1988. Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene. 71: 401-411.
7. Ueda, K., M. M. Cornwell, M. M. Gottesman, I. Pastan, I. B. Roninson, V. Ling, and J. R. Riordan. 1986. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Commun. 141: 956-962.
8. Morita, S. Y., A. Kobayashi, Y. Takanezawa, N. Kioka, T. Handa, H. Arai, M. Matsuo, and K. Ueda. 2007. Bile salt-dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4. Hepatology. 46: 188-199.
9. Kobayashi, A., Y. Takanezawa, T. Hirata, Y. Shimizu, K. Misasa, N. Kioka, H. Arai, K. Ueda, and M. Matsuo. 2006. Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J. Lipid Res. 47: 1791-1802.
10. Hirayama, H., Y. Kimura, N. Kioka, M. Matsuo, and K. Ueda. 2013. ATPase activity of human ABCG1 is stimulated by cholesterol and sphingomyelin. J. Lipid Res. 54: 496-502.
11. Sano, O., A. Kobayashi, K. Nagao, K. Kumagai, N. Kioka, K. Hanada, K. Ueda, and M. Matsuo. 2007. Sphingomyelin-dependence of cholesterol efflux mediated by ABCG1. J. Lipid Res. 48: 2377-2384.
12. Nagao, K., K. Takahashi, K. Hanada, N. Kioka, M. Matsuo, and K. Ueda. 2007. Enhanced apoA-I-dependent cholesterol efflux by ABCA1 from sphingomyelin-deficient Chinese hamster ovary cells. J. Biol. Chem. 282: 14868-14874.
13. Hanada, K. 2003. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim. Biophys. Acta. 1632: 16-30.
14. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1: 31-39.
15. Schuck, S., M. Honsho, K. Ekroos, A. Shevchenko, and K. Simons. 2003. Resistance of cell membranes to different detergents. Proc. Natl. Acad. Sci. USA. 100 : 5795-5800.
16. Drobnik, W., H. Borsukova, A. Bottcher, A. Pfeiffer, G. Liebisch, G. J. Schutz, H. Schindler, and G. Schmitz. 2002. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic. 3: 268-278.
17. Mendez, A. J., G. Lin, D. P. Wade, R. M. Lawn, and J. F. Oram. 2001. Membrane lipid domains distinct from cholesterol/sphingo-myelin- rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J. Biol. Chem. 276 : 3158-3166.
18. Morita, S. Y., T. Tsuda, M. Horikami, R. Teraoka, S. Kitagawa, and T. Terada. 2013. Bile salt-stimulated phospholipid efflux mediated by ABCB4 localized in nonraft membranes. J. Lipid Res. 54: 1221-1230.
19. Hozoji, M., Y. Munehira, Y. Ikeda, M. Makishima, M. Matsuo, N. Kioka, and K. Ueda. 2008. Direct interaction of nuclear liver X receptor-beta with ABCA1 modulates cholesterol efflux. J. Biol. Chem. 283: 30057-30063.
20. Ohta, K., T. Shibui, Y. Morimoto, S. Iijima, and T. Kobayashi. 1993. High level production of human proapo A-I by fed-batch culture of recombinant Escherichia coli. J. Ferment. Bioeng. 75: 155-157.
21. Yasuda, S., H. Kitagawa, M. Ueno, H. Ishitani, M. Fukasawa, M. Nishijima, S. Kobayashi, and K. Hanada. 2001. A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis. J. Biol. Chem. 276: 43994-44002. [additions and corrections: Yasuda, S., H. Kitagawa, M. Ueno, H. Ishitani, M. Fukasawa, M. Nishijima, S. Kobayashi, and K. Hanada. 2001. J. Biol. Chem. 288: 24162.].
22. Kumagai, K., S. Yasuda, K. Okemoto, M. Nishijima, S. Kobayashi, and K. Hanada. 2005. CERT mediates intermembrane transfer of various molecular species of ceramides. J. Biol. Chem. 280: 6488-6495.
23. Nagao, K., Y. Zhao, K. Takahashi, Y. Kimura, and K. Ueda. 2009. Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation. J. Lipid Res. 50: 1165-1172.
24. Vaughan, A. M., and J. F. Oram. 2003. ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J. Lipid Res. 44: 1373-1380.
25. Oram, J. F., A. M. Vaughan, and R. Stocker. 2001. ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J. Biol. Chem. 276 : 39898-39902.
26. Hojjati, M. R., and X. C. Jiang. 2006. Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J. Lipid Res. 47: 673-676.
27. Abe-Dohmae, S., S. Suzuki, Y. Wada, H. Aburatani, D. E. Vance, and S. Yokoyama. 2000. Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemistry. 39: 11092-11099.
28. Delgado, A., J. Casas, A. Llebaria, J. L. Abad, and G. Fabrias. 2006. Inhibitors of sphingolipid metabolism enzymes. Biochim. Biophys. Acta. 1758: 1957-1977.
29. Hanada, K., T. Hara, M. Fukasawa, A. Yamaji, M. Umeda, and M. Nishijima. 1998. Mammalian cell mutants resistant to a sphingo-myelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase. J. Biol. Chem. 273: 33787-33794.
30. Ueno, K., Y.-Y. Huang, A. Yamano, and S. Kobayashi. 2013. Revised stereochemistry of ceramide-trafficking inhibitor HPA-12 by X-ray crystallography analysis. Org. Lett. 15: 2869-2871.
31. ɰuriš, A., T. Wiesenganger, D. Moravčíková, P. Baran, J. Kožíšek, A. Daïch, and D. Berkeš. 2011. Expedient and practical synthesis of CERT-dependent ceramide trafficking inhibitor HPA-12 and its analogues. Org. Lett. 13: 1642-1645.
32. Hanada, K., K. Kumagai, S. Yasuda, Y. Miura, M. Kawano, M. Fukasawa, and M. Nishijima. 2003. Molecular machinery for nonvesicular trafficking of ceramide. Nature. 426 : 803-809.
33. Kudo, N., K. Kumagai, R. Matsubara, S. Kobayashi, K. Hanada, S. Wakatsuki, and R. Kato. 2010. Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer. J. Mol. Biol. 396: 245-251.
34. Wang, Y., B. W. O'Malley, and S. Y. Tsai. 1994. A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA. 91 : 8180-8184.
35. Ismair, M. G., S. Häusler, C. A. Stuermer, C. Guyot, P. J. Meier, J. Roth, and B. Stieger. 2009. ABC-transporters are localized in caveo-lin- 1-positive and reggie-1-negative and reggie-2-negative microdomains of the canalicular membrane in rat hepatocytes. Hepatology. 49 : 1673-1682.
36. Meier, P. J., E. S. Sztul, A. Reuben, and J. L. Boyer. 1984. Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J. Cell Biol. 98 : 991-1000.
37. Guyot, C., and B. Stieger. 2011. Interaction of bile salts with rat canalicular membrane vesicles: evidence for bile salt resistant microdomains. J. Hepatol. 55: 1368-1376.
38. Alvaro, D., F. Angelico, A. F. Attili, R. Antonini, B. Mazzarella, S. Ginanni Corradini, S. Gentile, F. Bracci, and M. Angelico. 1986. Plasma lipid lipoproteins and biliary lipid composition in female gallstone patients. Biomed. Biochim. Acta. 45: 761-768.